Healthcare Compliance, Regulation & Policy

McGuireWoods’ attorneys have the knowledge and experience healthcare providers need to assess and achieve compliance with federal and state-specific regulatory requirements. This group of more than 53 healthcare-focused attorneys advises clients on a range of regulatory and policy issues, including:

• Federal and state anti-kickback and fraud and abuse laws
• Federal and state self-referral laws, including the federal Stark Law
• Corporate practice of medicine restrictions
• False Claims Act
• Federal and state privacy laws, including the Health Insurance Portability and Accountability Act (HIPAA)
• Medicare and Medicaid conditions of participation
• Licensing, certification and certificate of need
• Restrictions on patient transfers, including the federal Emergency Medical Treatment and Active Labor Act (EMTALA)
• Health Care Quality Improvement Act
• Patient consent issues
• U.S. Food and Drug Administration regulations
• No Surprises Act
• Section 1557
• Eliminating Kickbacks in Recovery Act

McGuireWoods takes full advantage of the firm’s national network of 20 offices to advise clients on compliance with local, state and federal regulations in jurisdictions throughout the United States. Given the rate of change and level of uncertainty in this highly regulated industry, we update our clients regularly on national and local trends and pending legislation via frequent client alerts, newsletters and blogs, including The Healthcare Investor and The FCA Insider.

Representative matters include:

• Submission of Stark Law self-disclosures
• Submission of Office of Inspector General (OIG) self-disclosures
• Development of compliance programs, policies and procedures and associated training
• Negotiation of co-management agreements
• Evaluation of group practice compensation models for Stark Law compliance
• Change-of-ownership filings to various licensing and certification boards
• Healthcare diligence and the evaluation of healthcare providers for regulatory compliance
• Development of Surprise Billing policies, procedures and notifications
• Submission of OIG advisory opinions and Medicare reimbursement claim appeals